PDS Biotechnology Corporation
CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE

Last updated:

Abstract:

The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of augmenting an immune response in a mammal, and methods of treating diseases in a mammal utilizing the vaccine compositions.

Status:
Application
Type:

Utility

Filling date:

22 Jul 2021

Issue date:

11 Nov 2021